SOPHiA GENETICS announced at the Precision Medicine World Conference (PMWC) in Silicon Valley that its artificial intelligence, SOPHiA, has gained radiomics capabilities.
This year at SLAS 2018, the Formulatrix will be unveiling a concept for a novel automation platform that offers so many benefits to researchers preparing samples that it is surprising others have not beat them to the punch.
Beckman Coulter Life Sciences have launched a family of FormaPure reagent kits for extracting nucleic acid from often challenging formalin-fixed, paraffin-embedded (FFPE) tissues.
Sick and tired of dealing with generic drug shortages and unpredictable price increases, five large U.S. health systems are taking an unusual step: they’re forming their own nonprofit generic drugmaker.
In a scientific first, researchers turned skin cells from mice into stem cells by activating a specific gene in the cells using CRISPR technology.
Dawn Barry will be responsible for leading operations, communicating and implementing company mission, and guiding overall strategy, direction, and growth.
The new, next-generation sequencing (NGS) system delivers exceptional data accuracy, at a low capital cost, making Illumina technology available to virtually any lab.
Thermo Fisher Scientific and Illumina have announced a commercial agreement that enables Illumina to sell Ion AmpliSeq technology to researchers who conduct scientific studies on Illumina’s next-generation sequencing platforms.
Thermo Fisher Scientific Announce New NGS Technology to Enable Clinical Research in Liquid Biopsy and Immuno-Oncology
Thermo Fisher Scientific has expanded its Oncomine portfolio with new assays for liquid biopsy and immuno-oncology to complement its comprehensive solutions for clinical research
Thermo Fisher Scientific Introduces Ion GeneStudio S5 Series, A Line of Highly Versatile Next Generation Sequencers
Thermo Fisher Scientific announces the Ion GeneStudio S5 Series, a new line of benchtop NGS instruments that provide unmatched flexibility and scalability enabled by five Ion S5 chips, including the new Ion 550 chip, to facilitate wide-ranging experiments on a single platform.
To kick off the JP Morgan Healthcare Conference, Edico Genome and Genomics England announced a new partnership to strengthen the accuracy and consistency of next-generation sequencing (NGS) data analysis in Genomics England’s Rare Disease Pilot.
MilliporeSigma has signed a commercial supply agreement with bluebird bio for viral vector manufacturing, in the hopes of accelerating treatments for serious diseases.
Beckman Coulter has announced FDA clearance of its automated Access AMH immunoassay for in vitro diagnostic (IVD) use in the U.S.
A group of well-known companies aims to be the first to analyse brain scans together with genomic, clinical and phenotypic data to study neurodegenerative diseases at a population level, then distil it down to an individual’s personal treatment plan.
Thanks to their vertical solution, no one will need to guess who owns and has access to their genetic data.